1999/584/EC: Commission Decision of 28 July 1999 on financial assistance from the Community for storage in France, Italy and the United Kingdom of antigen for production of foot-and-mouth disease vaccine (notified under document number C(1999) 2449) (Text with EEA relevance) (Only the English, French and Italien texts are authentic)
Date: 1999-07-28
Institutions: European Commission
Subjects: EU aid, animal disease, financial aid, storage premium, vaccine, veterinary legislation

L 221/12

EN

Official Journal of the European Communities

21. 8. 1999

COMMISSION DECISION

of 28 July 1999

on financial assistance from the Community for storage in France, Italy and the United Kingdom of
antigen for production of foot-and-mouth disease vaccine

(notified under document number C(1999) 2449)

(Only the English, French and Italien texts are authentic)

(Text with EEA relevance)

(1999/584/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

HAS ADOPTED THIS DECISION:

Having regard to the Treaty establishing the European
Community,

Having regard to Council Decision 90/424/EEC of 26 June
1990 on expenditure in the veterinary field (1), as last amended
by Regulation (EC) No 1258/1999 (2), and in particular Article
14 thereof,

(1) Whereas, by virtue of Council Decision 91/666/EEC of
11 December 1991 establishing Community reserves of
foot-and-mouth disease vaccines (3), establishment of
antigen banks is part of the Community's action to
create Community reserves of foot-and-mouth disease
vaccine;

(2) Whereas Article 3 of that Decision designates the ‘Labo-
ratoire de pathologie bovine du Centre national d'études
vétérinaires et alimentaires’ at Lyon in France, the ‘Isti-
tuto Zooprofilattico Sperimentale di Brescia’ in Italy and
the ‘Institute for Animal Health’ at Pirbright
in the
United Kingdom as antigen banks holding Community
reserves;

(3) Whereas the functions and duties of these antigen banks
are specified in Article 4 of
that Decision; whereas
Community assistance must be conditional on accom-
plishment of these;

(4) Whereas Community financial assistance should be
granted to these banks to enable them to carry out
during 1999 the said functions and duties;

(5) Whereas for budgetary reasons the Community assis-

tance should be granted for a period of one year;

(6) Whereas for supervisory purposes Articles 8 and 9 of
Council Regulation (EEC) No 729/70 of 21 April 1970
on financing of the common agricultural policy (4), as
last amended by Regulation (EC) No 1287/95 (5), should
apply;

(7) Whereas the measures provided for in this Decision are
in accordance with the opinion of the Standing Veter-
inary Committee,

(1) OJ L 224, 18.8.1990, p. 19.
(2) OJ L 160, 26.6.1999, p. 103.
(3) OJ L 368, 31.12.1991, p. 21.
(4) OJ L 94, 28.4.1970, p. 13.
(5) OJ L 125, 8.6.1995, p. 1.

Article 1

The Community shall grant France financial assistance for
foot-and-mouth

1.
the stocking of antigen for production of
disease vaccine.

2.
The ‘Laboratoire de pathologie bovine du Centre national
d'études vétérinaires et alimentaires’ at Lyon in France shall
hold the stock of antigen to which paragraph 1 relates. The
provisions of Article 4 of Decision 91/666/EEC shall apply.

The Community's

3.
a
financial
maximum of EUR 40 000 for the period 1 January to 31
December 1999.

assistance

shall be

Article 2

The Community shall grant Italy financial assistance for
foot-and-mouth

1.
the stocking of antigen for production of
disease vaccine.

2.
in
The ‘Istituto Zooprofilattico Sperimentale di Brescia’
Italy shall hold the stock of antigen to which paragraph 1
relates. The provisions of Article 4 of Decision 91/666/EEC
shall apply.

The Community's

a
financial
3.
maximum of EUR 40 000 for the period 1 January to 31
December 1999.

assistance

shall be

Article 3

The Community shall grant the United Kingdom financial
the stocking of antigen for production of

1.
assistance for
foot-and-mouth disease vaccine.

2.
The Institute for Animal Health at Pirbright in the United
Kingdom shall hold the stock of antigen to which paragraph 1
relates. The provisions of Article 4 of Decision 91/666/EEC
shall apply.

The Community's

3.
a
financial
maximum of EUR 20 000 for the period 1 January to 31
December 1999.

assistance

shall be

21. 8. 1999

EN

Official Journal of the European Communities

L 221/13

Article 4

Article 5

The Community's

financial assistance referred to in
1.
Article 1(3), Article 2(3) and Article 3(3) of
the present
Decision shall be paid, following presentation, by the Member
State concerned, of supporting documents which demonstrate
the effective completion of the tasks.

2.
The supporting documents referred to in paragraph 1
must be presented to the Commission before 1 March 2000
and they should include:

(a) technical

information on:

— the amount and type of antigen stored (storage records),
— storage equipment used (type, number and capacity of

tanks),

— security system in place (temperature control, anti-theft

measures),

— insurance arrangements (fire, accidents);

(b) financial information (completion of table as shown in the

Annex).

Articles 8 and 9 of Regulation (EEC) No 729/70 shall apply
mutatis mutandis.

Article 6

This Decision is addressed to the French Republic, the Italian
Republic and the United Kingdom of Great Britain and
Northern Ireland.

Done at Brussels, 28 July 1999.

For the Commission

Franz FISCHLER

Member of the Commission

L 221/14

EN

Official Journal of the European Communities

21. 8. 1999

ANNEX

Financial information related to the storage of antigen for production of foot-and-mouth disease vaccine

STATEMENT OF COSTS

Reporting period: from . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . to . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Reference number of Commission Decision providing financial assistance: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Name and address of beneficiary:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Category of costs

Amount for the period
(National currency) (1)

1. Staff

2. Capital equipment

3. Consumables

4. Insurance

5. Rental of premises

(1) All costs must be expressed in national currency.

Total

Certificate by the beneficiary

We certify that:

— the above costs were incurred in connection with the tasks defined in the Decision and were essential to the sound

performance of those tasks,

— they are genuine costs falling within the definition of reimbursable costs,

— all the documents supporting the costs are available for audit purposes.

Date:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Name of technical director:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signature:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Date:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Person financially responsible: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signature:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .